Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 8NIH 2INDUSTRY 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2

Interventions

Cyclophosphamide 178Radiotherapy 147Paclitaxel 128Carboplatin 124Bevacizumab 123Cisplatin 119Doxorubicin 111Fluorouracil 107Etoposide 102Filgrastim 99Vincristine 88Leucovorin 82Bortezomib 80Gemcitabine 76aldesleukin 74Sorafenib 70Cytarabine 70Taxes 69fludarabine phosphate 67Irinotecan 66Docetaxel 64Oxaliplatin 60sargramostim 58Sirolimus 58temsirolimus 56Erlotinib Hydrochloride 56Methotrexate 55Rituximab 54Vorinostat 52Radiation 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × NIH × Raloxifene Hydrochloride × Clear all
NCT00031850 2013-06-26

Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer

National Cancer Institute (NCI)

Phase NA Completed
150 enrolled
Breast

Breast Neoplasms

NCT00019500 2013-06-20

Raloxifene in Preventing Breast Cancer in Premenopausal Women

National Cancer Institute (NCI)

Phase 2 Completed
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡